Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of PET Probe [68Ga]CBP8 in Radiation Induced Tissue Injury
NCT04485286Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2020
- Primary completion
- May 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Gallium Ga 68 NODAGA-CBP8 in radiation-induced lung injury (RILI), radiation fibrosis syndrome (RIF), sponsored by Massachusetts General Hospital. Started Jul 2020; status: recruiting.
02
Drugs
Gallium Ga 68 NODAGA-CBP8
03
Conditions
radiation-induced lung injury (RILI)radiation fibrosis syndrome (RIF)
Beyond the preview
Go deeper on NCT04485286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485286.